Evidence map›Paper›PMID 33012053›Full record

ReviewTropical medicine & international health : TM & IH2021

Comorbidities and the COVID-19 pandemic dynamics in Africa.

A A Anjorin, A I Abioye, O E Asowata, A Soipe, M I Kazeem, I O Adesanya, M A Raji, M Adesanya, F A Oke, F J Lawal and 2 more

Abstract readReview
In one paragraph

Review in Tropical medicine & international health : TM & IH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Rethinking the evidence on COVID-19 in Africa.The Lancet. Infectious diseases · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Coping mechanisms during the COVID-19 pandemic and lockdown in metropolitan Johannesburg, South Africa: A qualitative study.American journal of human biology : the official journal of the Human Biology Council · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A A AnjorinDepartment of Microbiology (Virology Research), Lagos State University, Ojo, Lagos, Nigeria.
A I AbioyePopulation Health Science Program & Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
O E AsowataAfrica Health Research Institute, Durban, South Africa.
A SoipeDepartment of Medicine, Division of Nephrology, Upstate Medical University, Syracuse, NY, USA.
M I KazeemDepartment of Biochemistry, Lagos State University, Ojo, Lagos, Nigeria.
I O AdesanyaBayou City Physicians, Houston, TX, USA.
M A RajiDepartment of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
M AdesanyaDepartment of Microbiology and Immunology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
F A OkeDepartment of Internal Medicine, Brookdale University Hospital Medical Centre, New York City, NY, USA.
F J LawalDepartment of Infectious Diseases, Medical College of Georgia, Augusta University, Augusta, GA, USA.
B A KasaliIndependent Researcher, Seattle, WA, USA.
M O OmotayoCentre for Global Health and Division of Pediatric Global Health, Massachusetts General Hospital, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The debate around the COVID-19 response in Africa has mostly focused on effects and implications of public health measures, in light of the socio-economic peculiarities of the continent. However, there has been limited exploration of the impact of differences in epidemiology of key comorbidities, and related healthcare factors, on the course and parameters of the pandemic. We summarise what is known about (a) the pathophysiological processes underlying the interaction of coinfections and comorbidities in shaping prognosis of COVID-19 patients, (b) the epidemiology of key coinfections and comorbidities, and the state of related healthcare infrastructure that might shape the course of the pandemic, and (c) implications of (a) and (b) for pandemic management and post-pandemic priorities. There is a critical need to generate empirical data on clinical profiles and the predictors of morbidity and mortality from COVID-19. Improved protocols for acute febrile illness and access to diagnostic facilities, not just for SARS-CoV-2 but also other viral infections, are of urgent importance. The role of malaria, HIV/TB and chronic malnutrition on pandemic dynamics should be further investigated. Although chronic non-communicable diseases account for a relatively lighter burden, they have a significant effect on COVID-19 prognosis, and the fragility of care delivery systems implies that adjustments to clinical procedures and re-organisation of care delivery that have been useful in other regions are unlikely to be feasible. Africa is a large region with local variations in factors that can shape pandemic dynamics. A one-size-fits-all response is not optimal, but there are broad lessons relating to differences in epidemiology and healthcare delivery factors, that should be considered as part of a regional COVID-19 response framework.

Indexed as

PandemicsAfricaCoinfectionComorbidityCOVID-19HumansAfricacoinfectionscomorbiditiesCOVID-19pandemicSARS-CoV-2

Identifiers

PMID33012053
PMCPMC7675305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.